LabCompass

Veronica Balatti

Medicine · The Ohio State University

Mid career · publishing since 2005

Publications

62

Citations

3,037

Est. group size

~2

Recurring co-author estimate

Active years

22

Publishing since 2005

Research summary
AI-generated

Veronica Balatti studies small non-coding RNAs, especially microRNAs (miR-155) and tRNA-derived fragments, and how they regulate gene expression in blood cancers such as chronic lymphocytic leukemia (CLL) and lymphoma. Her work explores how these RNA molecules affect immune recognition, tumor growth, and genetic stability, with an eye toward developing new diagnostic tools and targeted or immune-based therapies. Much of the research combines molecular biology experiments with genomic data analysis, including public database development for RNA fragment discovery.

MicroRNA regulation in cancerChronic lymphocytic leukemia (CLL) biologyNon-coding RNA and tRNA-derived fragmentsCancer immunotherapy and immune evasionGenomic and bioinformatic analysis of cancer RNA data

Publication output was higher and more variable earlier in the decade (e.g., 5-7 papers in 2017 and 2019) but has slowed to about 1 per year since 2020, with a low but steady recent output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
2017: 5 publications172018: 2 publications182019: 7 publications7192020: 2 publications20212022: 3 publications222023: 1 publication232024: 1 publication242025: 1 publication252026: 1 publication26
Publishes in
  • Proceedings of the National Academy of Sciences×8
  • Blood×2
  • Cancers×2
  • The Journal of Experimental Medicine×2
  • Cell Death and Differentiation×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile